Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Varela

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Journal of Hepatology|April 13, 2025
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCCLorenza Rimassa, Stephen L Chan, Bruno Sangro, et al.
The Lancet Regional Health. Southeast Asia|February 6, 2023
The COVID-19 laboratory response in Timor-Leste; a story of collaborationNevio Sarmento, Endang Soares da Silva, Ismael Barreto, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyMassimo Iavarone, Federica Invernizzi, Tommy Ivanics, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Journal of Hepatology|April 13, 2025
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCCLorenza Rimassa, Stephen L Chan, Bruno Sangro, et al.
The Lancet Regional Health. Southeast Asia|February 6, 2023
The COVID-19 laboratory response in Timor-Leste; a story of collaborationNevio Sarmento, Endang Soares da Silva, Ismael Barreto, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyMassimo Iavarone, Federica Invernizzi, Tommy Ivanics, et al.
Pageof 11